The study involved an assessment of medical history data and clinical features of psoriasis in 230 patients, of whom 182 suffered from isolated dermatosis and 48 from psoriasis with comorbid hypertension. The psoriasis group with concomitant arterial hypertension was found to have a significantly higher frequency of stressful situations (81% of cases as compared to 62%) and infectious diseases were registered less frequently (6% vs. 28%). Relapses of psoriasis in this group occurred more often, out-of-season type was observed more than 1.5 times more frequently and seasonal type of dermatosis was registered 2 times less often. Moreover, rapid dissemination of rash during exacerbations in patients with psoriasis with concomitant hypertension was observed two times as frequently (28% of cases vs. 16%), and cases of slow and gradual spread were more rare.
INTRODUCTION
The study of the association of psoriasis and cardiovascular diseases is now at the center of scientific interest of professionals around the world. Importance of clinical, social and economic aspects of this issue results in worldwide trials and objective multicenter researches of comorbidity of psoriasis and cardiovascular pathology. Their results allow to consider psoriasis as a risk factor for a wide range of cardiovascular diseases (hypertension, coronary heart disease, myocarditis, damage of the heart valves, atherosclerosis), which often develop at young age and, with prolonged course, lead to congestive heart failure and even death [1] [2] [3] [4] [5] . Some recent studies have shown clinical and metabolic disorders with violation of laboratory indications, specifical for comorbid psoriasis, which may have a pathogenic significance [6] [7] [8] [9] [10] [11] [12] [13] . Our prior studies revealed a high degree of comorbidity of psoriasis and arterial hypertension (more than 50%), among psoriatic inpatients.
Although we identified a definite comorbidity between psoriasis and different metabolic syndrome components, the degree of association of psoriasis and hypertension was the highest [14] [15] . However, the data published on that subject are not sufficient to get a full understanding of the clinical and prognostic significance of this nosology syntropy. The pathogenic and clinical relationship of this impairment is indisputable, which proves the need for better understanding of clinical implications of this comorbidity.
PURPOSES, SUBJECTS and METHODS:
2.1 Purpose of the research was to study the clinical features of psoriasis with comorbid arterial hypertension.
Subjects & Methods
The study involved two groups of patients with confirmed 
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RESULTS AND DISCUSSION
The total number of the patients with psoriasis included 230 patients, of them mild severity was diagnosed in 115 (50 %), moderately severe condition in 88 (38 %) and severe in 27 patients (12%). The age of the patients ranged from 40 to 65 years, an average of 52.7 ± 1.3. The study includ- 
CONCLUSIONS
Assessment of the features of clinical manifestations and course of psoriasis in patients with AH as compared to patients without AH showed significantly higher incidence of stress (81 % of cases versus 62 %) and lesser incidence of infections (6 % vs. 28 %), medication intake, allergies and alcohol abuse as trigger factors of psoriasis. Moreover, patients with AH comorbid psoriasis were found to have relapses more frequently. These patients more than 1.5 times more frequently had off-seasonal type and 2 times less seasonal type of dermatosis. Attention is drawn to the fact that rapid dissemination of skin lesions during exacerbation in patients with psoriasis, associated with AH, was observed 2 times more often (28 % of cases versus 16 %) and cases of slow and gradual dissemination of rash were rarer.
Thus, medical history data and clinical presentations of 230 psoriasis patients, including cases of comorbid arterial hypertension, are heterogeneous, aggravating by each other in various combinations that requires further study and systematization of key parameters.
